Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
227 hedge funds and large institutions have $3.1B invested in Inari Medical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 95 increasing their positions, 63 reducing their positions, and 26 closing their positions.
65% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 26
51% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 63
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
6% more funds holding
Funds holding: 214 → 227 (+13)
10% less capital invested
Capital invested by funds: $3.44B → $3.1B (-$334M)
43% less call options, than puts
Call options by funds: $7.49M | Put options by funds: $13.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$161M |
| 2 |
State Street
Boston,
Massachusetts
|
+$41.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.6M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$32.6M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$28.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$31.3M |
| 2 |
Millennium Management
New York
|
-$21.7M |
| 3 |
Jennison Associates
New York
|
-$20.9M |
| 4 |
JP Morgan Chase
New York
|
-$18.5M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$17.7M |
NARI Hedge Fund Activity: Q2 2022 in Review
227 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q2 2022, worth a combined $3.1B — down 9.7% from $3.44B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new NARI positions and 26 closed out — a net gain of 17 holders — while 95 added to existing stakes and 63 trimmed.
The largest buyer was BlackRock, adding an estimated $161M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $31.3M sold.
- 227 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q2 2022, up from 214 in Q1 2022.
- Funds reported $3.1B of Inari Medical, Inc. Common Stock stock for Q2 2022, down 9.7% quarter-over-quarter.
- 43 funds opened new Inari Medical, Inc. Common Stock positions in Q2 2022 and 26 closed out, a net change of +17 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $161M added.
- The largest Inari Medical, Inc. Common Stock seller in Q2 2022 was Point72 Asset Management, an estimated $31.3M sold.
Based on aggregated 13F filings for Q2 2022.